The Cellular Tumor Immune Microenvironment of Childhood Solid Cancers: Informing More Effective Immunotherapies

Area of Science:

• Pediatric Oncology
• Immunology
• Cancer Biology

Background:

• Standard immuno-oncology agents are ineffective against common pediatric solid tumors.
• Adoptive T cell transfer, including CAR-T cells, shows limited efficacy due to tumor microenvironment barriers.
• Understanding the tumor microenvironment is crucial for improving pediatric cancer immunotherapy.

Purpose of the Study:

• To review the cellular composition of the tumor microenvironment in pediatric extracranial solid tumors.
• To focus on the role of myeloid cell populations in these tumors.
• To present strategies for targeting immunosuppressive myeloid cells and enhancing T cell responses.

Main Methods:

• Literature review of current knowledge on pediatric solid tumor microenvironments.
• Analysis of cellular components, particularly myeloid cells.
• Synthesis of therapeutic strategies targeting myeloid cells and T cell cooperation.

Main Results:

• Pediatric solid tumors often contain abundant immunosuppressive myeloid cells.
• Local tumor microenvironment barriers hinder T cell infiltration and function.
• Myeloid cell populations significantly impact therapeutic immune responses.

Conclusions:

• Targeting immunosuppressive myeloid cells is a key strategy to overcome immunotherapy resistance in pediatric solid tumors.
• Combination therapies involving myeloid cell targeting and T cell-based approaches hold promise.
• Novel therapeutic concepts aim to leverage myeloid cells to support antitumor T cell activity.